Korean drug firms’ cash ratio falls in 2012

Published: 2013-05-22 06:59:00

Updated: 2013-05-22 06:59:00

Korea's overall cash asset ratio deteriorated in 2012 from a year earlier due to the government’s forced price cut for drugs and other medical products covered by national health insurance, a local pharmaceutical portal Yakup.com said Monday.

The average ratio of current assets to current liab...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK